Published in C R Acad Sci III on April 01, 1994
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol (1997) 3.32
Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet (2001) 2.66
Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol Cell Biol (2002) 1.81
Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci U S A (2001) 1.69
Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models. J Clin Invest (1998) 1.60
The role of laminins in basement membrane function. J Anat (1998) 1.45
Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival. J Cell Biol (1996) 1.42
The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review. J Med Genet (2001) 1.41
Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord (2014) 1.40
Non-muscle alpha-dystroglycan is involved in epithelial development. J Cell Biol (1995) 1.34
Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy. Hum Genet (1996) 1.24
Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a "mild Becker" phenotype. J Cell Biol (1996) 1.16
Paraffin wax embedded muscle is suitable for the diagnosis of muscular dystrophy. J Clin Pathol (2001) 1.15
Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality. Am J Pathol (2005) 1.15
Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies. Hum Mol Genet (2011) 1.09
Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies. Skelet Muscle (2011) 1.08
Extrasynaptic location of laminin beta 2 chain in developing and adult human skeletal muscle. Am J Pathol (1997) 1.07
Congenital muscular dystrophies: a brief review. Semin Pediatr Neurol (2011) 1.02
Merosin-deficient congenital muscular dystrophy (CMD): a study of 25 Brazilian patients using MRI. Pediatr Radiol (2005) 0.99
New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families. Neurogenetics (2003) 0.96
Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein. Am J Hum Genet (1996) 0.96
The muscular dystrophies. BMJ (1998) 0.96
Distribution of alpha-dystroglycan during embryonic nerve-muscle synaptogenesis. J Cell Biol (1995) 0.95
Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35-36. Am J Hum Genet (1998) 0.93
Laminin-211 in skeletal muscle function. Cell Adh Migr (2012) 0.92
Feeding problems in merosin deficient congenital muscular dystrophy. Arch Dis Child (1999) 0.91
Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42. Am J Hum Genet (2000) 0.88
Laminin α2 Chain-Deficiency is Associated with microRNA Deregulation in Skeletal Muscle and Plasma. Front Aging Neurosci (2014) 0.88
Refinement of the laminin alpha2 chain locus to human chromosome 6q2 in severe and mild merosin deficient congenital muscular dystrophy. J Med Genet (1997) 0.88
PCR based mutation screening of the laminin alpha2 chain gene (LAMA2): application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy. J Med Genet (1998) 0.86
Congenital muscular dystrophy type 1A with residual merosin expression. Korean J Pediatr (2014) 0.86
The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy. FEBS J (2013) 0.85
Omigapil treatment decreases fibrosis and improves respiratory rate in dy(2J) mouse model of congenital muscular dystrophy. PLoS One (2013) 0.85
Thrombospondin-4 controls matrix assembly during development and repair of myotendinous junctions. Elife (2014) 0.84
Diseased muscles that lack dystrophin or laminin-alpha2 have altered compositions and proliferation of mononuclear cell populations. BMC Neurol (2005) 0.83
Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2. BMC Res Notes (2011) 0.83
Brain alterations in the classical form of congenital muscular dystrophy. Clinical and neuroimaging follow-up of 12 cases and correlation with the expression of merosin in muscle. Childs Nerv Syst (1996) 0.82
Interaction of merosin (laminin 2) with very late activation antigen-6 is necessary for the survival of CD4+ CD8+ immature thymocytes. Immunology (2000) 0.80
Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation. J Cell Biol (1996) 0.80
Abnormalities of dystrophin, the sarcoglycans, and laminin alpha2 in the muscular dystrophies. J Med Genet (1998) 0.79
Tendon development and musculoskeletal assembly: emerging roles for the extracellular matrix. Development (2015) 0.79
Merosin-deficient congenital muscular dystrophy type 1A: A case report. Exp Ther Med (2013) 0.78
Prevalence of congenital muscular dystrophy in Italy: a population study. Neurology (2015) 0.77
Novel sequence variations in LAMA2 andSGCG genes modulating cis-acting regulatory elements and RNA secondary structure. Genet Mol Biol (2010) 0.77
Recent advances in muscular dystrophies and myopathies. J Clin Pathol (1995) 0.76
Laminin α2 Deficiency-Related Muscular Dystrophy Mimicking Emery-Dreifuss and Collagen VI related Diseases. J Neuromuscul Dis (2015) 0.76
Magnetic Resonance Imaging Is Sensitive to Pathological Amelioration in a Model for Laminin-Deficient Congenital Muscular Dystrophy (MDC1A). PLoS One (2015) 0.75
Severe dystrophinopathy in a patient with congenital hypotonia. Childs Nerv Syst (1996) 0.75
Promoting differentiation of cultured myoblasts using biomimetic surfaces that present alpha-laminin-2 peptides. Cytotechnology (2016) 0.75
Congenital muscular dystrophy with severe retrocollis and mental retardation: a report of two siblings. J Neurol Neurosurg Psychiatry (1997) 0.75
Congenital muscular dystrophy with inflammation: Diagnostic considerations. Ann Indian Acad Neurol (2016) 0.75
Investigation of muscle disease. J Neurol Neurosurg Psychiatry (1996) 0.75
A novel early onset phenotype in a zebrafish model of merosin deficient congenital muscular dystrophy. PLoS One (2017) 0.75
Ring chromosome 18 in combination with 18q12.1 (DTNA) interstitial microdeletion in a patient with multiple congenital defects. Mol Cytogenet (2016) 0.75
Muscle MRI findings in a one-year-old girl with merosin-deficient congenital muscular dystrophy type 1A due to LAMA2 mutation: A case report. Biomed Rep (2017) 0.75
Alterations of the retino-cortical conduction in patients affected by classical congenital muscular dystrophy (CI-CMD) with merosin deficiency. Doc Ophthalmol (1999) 0.75
Membrane organization of the dystrophin-glycoprotein complex. Cell (1991) 6.64
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature (1992) 6.37
Structural evidence for direct interaction between the molecular components of the transverse tubule/sarcoplasmic reticulum junction in skeletal muscle. J Cell Biol (1988) 6.30
Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science (1998) 5.83
A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol (1993) 5.73
Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet (1999) 5.04
A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet (1998) 4.75
Purified ryanodine receptor from rabbit skeletal muscle is the calcium-release channel of sarcoplasmic reticulum. J Gen Physiol (1988) 4.56
Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet (1998) 4.38
Calcium channel beta-subunit binds to a conserved motif in the I-II cytoplasmic linker of the alpha 1-subunit. Nature (1994) 4.34
The naming of voltage-gated calcium channels. Neuron (1994) 4.31
Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature (1990) 4.23
Validity of self-reported weight and height in the French GAZEL cohort. Int J Obes Relat Metab Disord (2000) 4.20
Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature (1990) 3.77
Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet (1998) 3.62
Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med (2000) 3.50
Sequence and expression of mRNAs encoding the alpha 1 and alpha 2 subunits of a DHP-sensitive calcium channel. Science (1988) 3.38
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol (1997) 3.32
The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit. Nat Genet (1998) 3.31
Purified ryanodine receptor from skeletal muscle sarcoplasmic reticulum is the Ca2+-permeable pore of the calcium release channel. J Biol Chem (1987) 3.25
Nomenclature of voltage-gated calcium channels. Neuron (2000) 3.09
Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet (1995) 3.05
Socioeconomic, demographic, occupational, and health factors associated with participation in a long-term epidemiologic survey: a prospective study of the French GAZEL cohort and its target population. Am J Epidemiol (2001) 3.01
Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature (1992) 2.76
Autopsies of sudden infant death syndrome--classification and epidemiology. Acta Paediatr (1995) 2.75
Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet (1997) 2.69
Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol (1991) 2.68
Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet (2001) 2.66
Molecular basis of muscular dystrophies. Muscle Nerve (2000) 2.65
Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature (1993) 2.63
Direct binding of G-protein betagamma complex to voltage-dependent calcium channels. Nature (1997) 2.60
Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell (1999) 2.57
Ryanodine receptor of skeletal muscle is a gap junction-type channel. Science (1988) 2.56
Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med (1999) 2.50
The ryanodine receptor/Ca2+ release channel. J Biol Chem (1993) 2.50
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet (2001) 2.45
Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol (1998) 2.44
Staining of the Ca2+-binding proteins, calsequestrin, calmodulin, troponin C, and S-100, with the cationic carbocyanine dye "Stains-all". J Biol Chem (1983) 2.40
A role for dystroglycan in basement membrane assembly. Cell (1998) 2.36
Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy. Lancet (1993) 2.33
Chapter 2. European guidelines for prevention in low back pain : November 2004. Eur Spine J (2006) 2.31
Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron (1991) 2.30
Psychosocial factors at work and sickness absence in the Gazel cohort: a prospective study. Occup Environ Med (1998) 2.27
Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci U S A (1999) 2.27
Psychosocial factors at work and subsequent depressive symptoms in the Gazel cohort. Scand J Work Environ Health (1998) 2.21
The Ca2+-release channel/ryanodine receptor is localized in junctional and corbular sarcoplasmic reticulum in cardiac muscle. J Cell Biol (1993) 2.18
Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology (2000) 2.16
Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet (1995) 2.16
Muscular dystrophies and the dystrophin-glycoprotein complex. Curr Opin Neurol (1997) 2.13
Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J Cell Biol (1991) 2.10
The brain ryanodine receptor: a caffeine-sensitive calcium release channel. Neuron (1991) 2.05
Isolation, characterization, and localization of the inositol 1,4,5-trisphosphate receptor protein in Xenopus laevis oocytes. J Biol Chem (1992) 2.05
[Changing social disparities and mortality in France (1968-1996): cause of death analysis by educational level]. Rev Epidemiol Sante Publique (2007) 2.05
Dual function of the voltage-dependent Ca2+ channel alpha 2 delta subunit in current stimulation and subunit interaction. Neuron (1996) 2.04
Induction of calcium currents by the expression of the alpha 1-subunit of the dihydropyridine receptor from skeletal muscle. Nature (1989) 2.04
Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin--glycoprotein complex. Neuron (2000) 2.04
Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan. J Cell Biol (2001) 2.03
Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science (1998) 2.02
The biochemistry and molecular biology of the dihydropyridine-sensitive calcium channel. Trends Neurosci (1988) 1.98
Further characterization of light and heavy sarcoplasmic reticulum vesicles. Identification of the 'sarcoplasmic reticulum feet' associated with heavy sarcoplasmic reticulum vesicles. Biochim Biophys Acta (1980) 1.96
Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med (1999) 1.94
Ca2+ channel regulation by a conserved beta subunit domain. Neuron (1994) 1.92
Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. J Cell Biol (2000) 1.92
Association of triadin with the ryanodine receptor and calsequestrin in the lumen of the sarcoplasmic reticulum. J Biol Chem (1995) 1.86
Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics. J Virol (2001) 1.85
Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol (2000) 1.84
Subcellular fractionation of dystrophin to the triads of skeletal muscle. Nature (1988) 1.81
The central nervous system and carbon monoxide poisoning. II. Anatomical study of brain lesions following intoxication with carbon monixide (22 cases). Prog Brain Res (1967) 1.80
A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering. Cell (1994) 1.80
Identification and characterization of the high affinity [3H]ryanodine receptor of the junctional sarcoplasmic reticulum Ca2+ release channel. J Biol Chem (1987) 1.80
Forced expression of dystrophin deletion constructs reveals structure-function correlations. J Cell Biol (1996) 1.79
Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve (1994) 1.78
Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem (1998) 1.77
Differential immunohistochemical localization of inositol 1,4,5-trisphosphate- and ryanodine-sensitive Ca2+ release channels in rat brain. J Neurosci (1993) 1.76
Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul Disord (1991) 1.75
Congenital muscular dystrophy with rigid spine syndrome: a clinical, pathological, radiological, and genetic study. Ann Neurol (2000) 1.75
A beta 4 isoform-specific interaction site in the carboxyl-terminal region of the voltage-dependent Ca2+ channel alpha 1A subunit. J Biol Chem (1998) 1.71
Cloning and tissue-specific expression of the brain calcium channel beta-subunit. FEBS Lett (1991) 1.70
Dystroglycan inside and out. Curr Opin Cell Biol (1999) 1.70
Structural characterization of the 1,4-dihydropyridine receptor of the voltage-dependent Ca2+ channel from rabbit skeletal muscle. Evidence for two distinct high molecular weight subunits. J Biol Chem (1987) 1.70
Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature (1992) 1.70
Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat Genet (1994) 1.70
Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem (1995) 1.67
Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Mol Cell (2000) 1.66
Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord (1991) 1.65
Polyneuropathy after perhexiline maleate therapy. Br Med J (1976) 1.64
Subunit regulation of the neuronal alpha 1A Ca2+ channel expressed in Xenopus oocytes. J Physiol (1995) 1.63
Structural characterization of the dihydropyridine-sensitive calcium channel alpha 2-subunit and the associated delta peptides. J Biol Chem (1991) 1.63
Primary structure of the gamma subunit of the DHP-sensitive calcium channel from skeletal muscle. Science (1990) 1.62
SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem (1995) 1.61
Purification and characterization of calsequestrin from canine cardiac sarcoplasmic reticulum and identification of the 53,000 dalton glycoprotein. J Biol Chem (1983) 1.60
High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol (2000) 1.58
Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol (1999) 1.58
Psychosocial work environment and cardiovascular risk factors in an occupational cohort in France. J Epidemiol Community Health (1998) 1.58
Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol (1999) 1.58
Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy. N Engl J Med (1996) 1.57